Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) Book/Monograph |
| Language: | English |
| Published: |
London
BioMed Central
06 December 2017
|
| DOI: | https://doi.org/10.1186/s12920-017-0308-8 |
| Online Access: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12920-017-0308-8 Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-243051 
|
| Author Notes: | Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher and Albrecht Stenzinger |
MARC
| LEADER | 00000cam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1655268554 | ||
| 003 | DE-627 | ||
| 005 | 20221103081902.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180430s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a urn:nbn:de:bsz:16-heidok-243051 |2 urn | |
| 024 | 7 | |a 10.1186/s12920-017-0308-8 |2 doi | |
| 035 | |a (DE-627)1655268554 | ||
| 035 | |a (DE-576)502466596 | ||
| 035 | |a (DE-599)BSZ502466596 | ||
| 035 | |a (OCoLC)1033916707 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Budczies, Jan |d 1970- |e VerfasserIn |0 (DE-588)124086403 |0 (DE-627)706532724 |0 (DE-576)186167679 |4 aut | |
| 245 | 1 | 0 | |a Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types |c Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher and Albrecht Stenzinger |
| 264 | 1 | |a London |b BioMed Central |c 06 December 2017 | |
| 300 | |a 1 Online-Ressource (8 Seiten) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Aus: BMC Medical Genomics, 10 (2017), Nr. 74. pp. 1-8. ISSN 1755-8794 | ||
| 700 | 1 | |a Schirmacher, Peter |d 1961- |e VerfasserIn |0 (DE-588)1020440112 |0 (DE-627)691221197 |0 (DE-576)360427448 |4 aut | |
| 700 | 1 | |a Stenzinger, Albrecht |e VerfasserIn |0 (DE-588)139606106 |0 (DE-627)703395238 |0 (DE-576)312432755 |4 aut | |
| 856 | 4 | 0 | |u http://dx.doi.org/https://doi.org/10.1186/s12920-017-0308-8 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-243051 |q application/pdf |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a BO | ||
| 992 | |a 20180430 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 139606106 |a Stenzinger, Albrecht |m 139606106:Stenzinger, Albrecht |d 910000 |d 912000 |e 910000PS139606106 |e 912000PS139606106 |k 0/910000/ |k 1/910000/912000/ |p 5 |y j | ||
| 998 | |g 1020440112 |a Schirmacher, Peter |m 1020440112:Schirmacher, Peter |d 910000 |d 912000 |e 910000PS1020440112 |e 912000PS1020440112 |k 0/910000/ |k 1/910000/912000/ |p 4 | ||
| 999 | |a KXP-PPN1655268554 |e 337914455X | ||
| BIB | |a Y | ||
| JSO | |a {"physDesc":[{"extent":"1 Online-Ressource (8 Seiten)"}],"type":{"media":"Online-Ressource","bibl":"book"},"note":["Aus: BMC Medical Genomics, 10 (2017), Nr. 74. pp. 1-8. ISSN 1755-8794"],"origin":[{"dateIssuedDisp":"06 December 2017","dateIssuedKey":"2017","publisherPlace":"London","publisher":"BioMed Central"}],"recId":"1655268554","person":[{"role":"aut","family":"Budczies","display":"Budczies, Jan","roleDisplay":"VerfasserIn","given":"Jan"},{"family":"Schirmacher","role":"aut","roleDisplay":"VerfasserIn","given":"Peter","display":"Schirmacher, Peter"},{"roleDisplay":"VerfasserIn","given":"Albrecht","display":"Stenzinger, Albrecht","family":"Stenzinger","role":"aut"}],"title":[{"title":"Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types","title_sort":"Chromosome 9p copy number gains involving PD-L1 are associated with a specific proliferation and immune-modulating gene expression program active across major cancer types"}],"language":["eng"],"id":{"eki":["1655268554"],"uri":["urn:nbn:de:bsz:16-heidok-243051"],"doi":["10.1186/s12920-017-0308-8"]},"name":{"displayForm":["Jan Budczies, Carsten Denkert, Balázs Győrffy, Peter Schirmacher and Albrecht Stenzinger"]}} | ||
| SRT | |a BUDCZIESJACHROMOSOME0620 | ||